Disclosures for "Evaluating the Utility of Biomarker in Assessing Symptoms of Patients with CSF1R-related Disorders"
-
Dr. Chmiela has nothing to disclose.
-
Prof. Prudencio has received research support from Novoglia.
-
Dr. Petrucelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Expansion Therapeutic . The institution of Dr. Petrucelli has received research support from Biogen. The institution of Dr. Petrucelli has received research support from Novoglia.
-
Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica.